X4 PHARMACEUTICALS INC. - COMMON STOCK

X4 Pharmaceuticals Expands Commercial Leadership Expertise with Appointment of Françoise de Craecker to Board of Directors and Karolyn Park as Vice President, U.S. Commercial

19 أكتوبر 2021 07:00:02 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals Completes Enrollment in Phase 3 Mavorixafor Trial in Patients with WHIM Syndrome

04 أكتوبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 أكتوبر 2021 15:05:00 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals to Participate in Upcoming Investor Conferences

15 سبتمبر 2021 15:05:00 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals Promotes Mary DiBiase, Ph.D. to Chief Operating Officer

08 سبتمبر 2021 07:00:04 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 سبتمبر 2021 15:01:00 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences

01 سبتمبر 2021 07:00:03 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals to Participate at Canaccord Genuity’s Virtual 41st Annual Growth Conference

04 أغسطس 2021 15:01:00 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals Announces Key Enrollment Milestone Achievements in Ongoing Mavorixafor Clinical Trials and Reports Second Quarter Financial Results

03 أغسطس 2021 07:00:01 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host a Conference Call and Webcast on August 3, 2021

22 يوليو 2021 15:05:00 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 يوليو 2021 15:01:00 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia at EHA 2021

11 يونيو 2021 02:00:00 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals to Host Conference Call and Webcast to Present Initial Efficacy and Safety Data from EHA 2021 Poster on Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia

26 مايو 2021 07:00:01 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals to Participate in Two May Virtual Investor Conferences

17 مايو 2021 07:00:02 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals Announces Positive Preliminary Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia as Published in EHA Abstract

12 مايو 2021 09:00:00 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

06 مايو 2021 07:00:02 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 مايو 2021 15:01:00 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host a Conference Call and Webcast on May 6, 2021

22 أبريل 2021 07:00:01 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference

07 أبريل 2021 07:00:01 بحسب Nasdaq GlobeNewswire

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 أبريل 2021 15:05:00 بحسب Nasdaq GlobeNewswire